Journal of Gastric Cancer

The Korean Gastric Cancer Association (대한위암학회)
권호 표지
DOI QR코드

DOI QR Code

The Impact of an Increased Application of Critical Pathway for Gastrectomy on the Length of Stay and Cost

  • Seo, Ho-Seok (Division of Gastrointestinal Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Song, Kyo-Young (Division of Gastrointestinal Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Jeon, Hae-Myung (Division of Gastrointestinal Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Park, Cho-Hyun (Division of Gastrointestinal Surgery, Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2012.03.18
  • Accepted : 2012.06.08
  • Published : 2012.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: We developed a standardized critical pathway for gastric cancer surgery and then determined the increase of application, which resulted in an improvement in terms of measurable indices, such as hospital stay and cost. Materials and Methods: A critical pathway was revised and used widely from the 2nd quarter of 2009. We collected clinical data, such as length of stay and complication rate, as clinical indices of quality prospectively. The total cost paid at the patient's discharge, as well as the daily hospital income, were calculated and compared by each quarter from January 2008 to December 2009. Results: The application rate of critical pathway was 11.8% and 87.8% in 2008 and 2009, respectively. There were no perioperative deaths. There was no difference in the complication rates between 2008 and 2009 (P=0.45). However, the mean length of stay was significantly different between the 2 years (P<0.05). Although the total cost was not different, the daily hospital income was significantly higher in the latter year (P<0.05). Conclusions: An increase in the application of critical pathway for gastrectomy resulted in significant decreases in length of stay and increases in the daily hospital income without a compromise on the clinical indices.

Keywords

References

  1. Park CH, Song KY, Kim SN. Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surg Oncol 2008;34:36-41. https://doi.org/10.1016/j.ejso.2007.03.004
  2. Melbert RB, Kimmins MH, Isler JT, Billingham RP, Lawton D, Salvadalena G, et al. Use of a critical pathway for colon resections. J Gastrointest Surg 2002;6:745-752. https://doi.org/10.1016/S1091-255X(02)00038-0
  3. Coffey RJ, Richards JS, Remmert CS, LeRoy SS, Schoville RR, Baldwin PJ. An introduction to critical paths. Qual Manag Health Care 2005;14:46-55. https://doi.org/10.1097/00019514-200501000-00006
  4. Pritts TA, Nussbaum MS, Flesch LV, Fegelman EJ, Parikh AA, Fischer JE. Implementation of a clinical pathway decreases length of stay and cost for bowel resection. Ann Surg 1999;230:728-733. https://doi.org/10.1097/00000658-199911000-00017
  5. Archer SB, Burnett RJ, Flesch LV, Hobler SC, Bower RH, Nussbaum MS, et al. Implementation of a clinical pathway decreases length of stay and hospital charges for patients undergoing total colectomy and ileal pouch/anal anastomosis. Surgery 1997;122:699-703. https://doi.org/10.1016/S0039-6060(97)90076-3
  6. Porter GA, Pisters PW, Mansyur C, Bisanz A, Reyna K, Stanford P, et al. Cost and utilization impact of a clinical pathway for patients undergoing pancreaticoduodenectomy. Ann Surg Oncol 2000;7:484-489. https://doi.org/10.1007/s10434-000-0484-0
  7. Delaney CP, Zutshi M, Senagore AJ, Remzi FH, Hammel J, Fazio VW. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 2003;46:851-859. https://doi.org/10.1007/s10350-004-6672-4
  8. Song KY, Kim SN, Park CH. Critical pathway for operable gastric cancer. J Korean Gastric Cancer Assoc 2005;5:95-100.
  9. Hur H, Song KY, Park CH, Jeon HM. Follow-up strategy after curative resection of gastric cancer: a nationwide survey in Korea. Ann Surg Oncol 2010;17:54-64. https://doi.org/10.1245/s10434-009-0676-1
  10. Strong VE, Song KY, Park CH, Jacks LM, Gonen M, Shah M, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-646. https://doi.org/10.1097/SLA.0b013e3181d3d29b

Cited by

  1. Impact of a Clinical Pathway on Hospital Costs, Length of Stay and Early Outcomes after Hepatectomy for Hepatocellular Carcinoma vol.15, pp.13, 2014, https://doi.org/10.7314/apjcp.2014.15.13.5389
  2. Use of a clinical pathway in laparoscopic gastrectomy for gastric cancer vol.21, pp.48, 2015, https://doi.org/10.3748/wjg.v21.i48.13507
  3. Analysis of patient-dropouts from the critical pathways for gastric cancer vol.88, pp.6, 2012, https://doi.org/10.4174/astr.2015.88.6.311